Patents by Inventor Odile Peroni

Odile Peroni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RBP4 IN INSULIN SENSITIVITY/RESISTANCE, DIABETES, AND OBESITY
    Publication number: 20140044737
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Application
    Filed: October 24, 2013
    Publication date: February 13, 2014
    Applicant: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • RBP4 in insulin sensitivity/resistance, diabetes, and obesity
    Patent number: 8568969
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: October 29, 2013
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • RBP4 IN INSULIN SENSITIVITY/RESISTANCE, DIABETES, AND OBESITY
    Publication number: 20120295950
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Application
    Filed: May 22, 2012
    Publication date: November 22, 2012
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • RBP4 in insulin sensitivity/resistance, diabetes, and obesity
    Patent number: 8231862
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: July 31, 2012
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • RBP4 In Insulin sensitivity/resistance, diabetes, and obesity
    Publication number: 20100009363
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Application
    Filed: June 1, 2009
    Publication date: January 14, 2010
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • RBP4 in insulin sensitivity/resistance, diabetes, and obesity
    Patent number: 7553631
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: June 30, 2009
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Barbara B. Kahn, Qin Yang, Tim Graham, Odile Peroni
  • Modulation of type IIß phosphoinositide phosphate kinase
    Publication number: 20060089320
    Abstract: The invention provides methods for modulating type II? phosphoinisitide phosphate kinase (PIPKII?) activity for treating PIPKII?-associated disorders. The invention also provides methods of identifying candidate agents for treating PIPKII?-associated disorders.
    Type: Application
    Filed: February 3, 2003
    Publication date: April 27, 2006
    Inventors: Lewis Cantley, Katja Lamia, Lucia Rameh, Barbara Kahn, Odile Peroni
  • RBP4 in insulin sensitivity/resistance, diabetes, and obesity
    Publication number: 20050208535
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Application
    Filed: December 10, 2004
    Publication date: September 22, 2005
    Inventors: Barbara Kahn, Qin Yang, Tim Graham, Odile Peroni